These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece. Syriopoulou V; Kafetzis D; Theodoridou M; Syrogiannopoulos GA; Mantagos S; Trimis G; Mavrikou M; Konstantopoulos A Acta Paediatr; 2011 May; 100(5):732-9. PubMed ID: 21223372 [TBL] [Abstract][Full Text] [Related]
6. Rotavirus immunisation in Africa: a perspective re-visited. Steele D Afr J Health Sci; 2002; 9(3-4):113-6. PubMed ID: 17298153 [No Abstract] [Full Text] [Related]
8. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America. Desai R; Parashar UD; Lopman B; de Oliveira LH; Clark AD; Sanderson CF; Tate JE; Matus CR; Andrus JK; Patel MM Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803 [TBL] [Abstract][Full Text] [Related]
9. Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines. Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S377-82. PubMed ID: 26590437 [TBL] [Abstract][Full Text] [Related]
10. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand. Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220 [TBL] [Abstract][Full Text] [Related]
11. Preparing for the scale-up of rotavirus vaccine introduction in Africa: establishing surveillance platforms to monitor disease burden and vaccine impact. Mwenda JM; Tate JE; Steele AD; Parashar UD Pediatr Infect Dis J; 2014 Jan; 33 Suppl 1():S1-5. PubMed ID: 24343605 [TBL] [Abstract][Full Text] [Related]
13. Time to begin a new chapter and expand rotavirus immunization. Anderson EJ Clin Infect Dis; 2014 Oct; 59(7):982-6. PubMed ID: 24944227 [TBL] [Abstract][Full Text] [Related]
14. Rotavirus vaccine: a welcome addition to the immunisation schedule in the UK. Iturriza-Gómara M; Cunliffe N BMJ; 2013 Apr; 346():f2347. PubMed ID: 23587749 [No Abstract] [Full Text] [Related]
15. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901 [TBL] [Abstract][Full Text] [Related]
16. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants. Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513 [TBL] [Abstract][Full Text] [Related]
17. Rotavirus vaccines for children in developing countries: understanding the science, maximizing the impact, and sustaining the effort. Neuzil KM; Parashar UD; Steele AD Vaccine; 2012 Apr; 30 Suppl 1():A1-2. PubMed ID: 22520117 [No Abstract] [Full Text] [Related]
18. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030. Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139 [TBL] [Abstract][Full Text] [Related]
19. Rotavirus vaccines in Belgium: policy and impact. Braeckman T; Van Herck K; Raes M; Vergison A; Sabbe M; Van Damme P Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S21-4. PubMed ID: 21183836 [TBL] [Abstract][Full Text] [Related]
20. The rotavirus experience in Mexico: discovery to control. Patel MM; Parashar UD; Santosham M; Richardson V Clin Infect Dis; 2013 Feb; 56(4):548-51. PubMed ID: 23271788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]